Opportunities lie ahead at the 39th ‘hybrid’ ESCRS
September 20th 2021The 39th Congress of the European Society for Cataract and Refractive Surgery (ESCRS) will meet at RAI Congress Centre in Amsterdam, the Netherlands, from 8–11 October 2021. The Congress will also be held virtually, making the chance to participate in some capacity a reality for all.
LIGHTSITE II study: Photobiomodulation treatment improves vision in eyes with dry AMD
September 12th 2021During a presentation at the EURETINA 2021 Virtual Congress, Prof. Ben Burton detailed how dry AMD patients treated with photobiomodulation therapy have seen improvements in best-corrected visual acuity 9 months after treatment.
Brolucizumab injection improves vision in eyes with neovascular AMD
September 11th 2021In a presentation at the EURETINA 2021 Virtual Congress, Dr Cristina Cristian noted that an injection of brolucizumab treatment in patients with neovascular age-related macular degeneration led to a median improvement in visual acuity (VA) of 10.5 letters and the drug was well-tolerated.
Addressing roadblocks of treating peripheral hemorrhagic polypoidal choroidal vasculopathy
September 9th 2021Treating the disease can be a challenge, and at the EURETINA 2021 Virtual Congress, Dr Chekitaan Singh discussed a case study detailing the care of a patient who had already lost vision in one eye from a similar issue.
Autoimmune uveitis targeted by AAV gene therapy
September 8th 2021Investigators have found that 1 intravitreal injection of an adeno-associated virus encoding an immunosuppressive transgene, either HLA-G or eqIL-10, reduced the clinical and histologic inflammation in a well-established model of autoimmune uveitis.
Examining the link between neurodevelopmental disorders and visual problems
August 27th 2021Children with certain neurodevelopmental disorders show altered ocular movements and a more reduced amplitude of accommodation, however, vision problems are not always present in these children and so cannot be considered an aetiological factor.